TNF and COVID-19: TNF-ɑ, one of the increased cytokines in the course of COVID-19, triggers an increase in plasminogen activator inhibitor-1, which inhibits tissue plasminogen activator, which leads to a decrease in plasmin activity, reducing fibrinolysis.